This Feature written by Prof. Zongru Guo is a timely account highlighting the most important aspects of the artemisinin story, including the initial discovery of artemisinin as the active component, subsequent structural characterization, total synthesis, and structural modification, as well as the identification and clinical validation of the most important antimalarial drugs artemether, artesunate and dihydroartemisinin. From a medicinal chemist's viewpoint, this review also provides expert discussions on the QSAR, structure-based physico-chemical properties, drug-likeness developments, and formulation studies of artemisinin analogs. As emphasized, the success of artemisinin was the fruit of collaborative teamwork by a large number of multidisciplinary scientists, including natural product chemists who identified the active compound from natural sources, organic chemists who elucidated the precise chemical structure, medicinal chemists who tuned the safety profiles through structural optimization, and pharmacologists and clinicians who made tremendous efforts to validate the effects of artemisinin and its analogs both in vitro and in vivo. In the meantime, we have to be aware that the success of artemisinin or the recognition by the Nobel Prize does not mean that the fight against the tropical disease is over; instead, we have to work much harder to find new and further improved treatments since drug resistance to artemisinin therapies has already been reported.
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